BioSpace News Archive

Nephron Pharmaceuticals Corporation today announced a new partnership with National Medical Products Inc. – developer of the J-Tip Needle Free Injector – that provides patients with an easy-to-use and virtually pain-free delivery of anesthetic medications prior to medical procedures.

The U.S. Food and Drug Administration has approved three applications for first generics of Gilenya (fingolimod) capsules for the treatment of relapsing forms of multiple sclerosis (MS) in adult patients.

Codexis, Inc., a leading protein engineering company, announces the publication with Merck, known as MSD outside the United States and Canada, of a paper in the prestigious peer-reviewed journal Science, detailing the development of a novel, highly efficient enzymatic cascade for the production of Merck’s investigational nucleoside reverse transcriptase translocation inhibitor, islatravir.

IVERIC bio, Inc., announced that it is commencing an underwritten public offering of shares of its common stock.

BIOASIS TECHNOLOGIES INC. is pleased to announce that all resolutions were passed by the requisite majority at its annual general meeting held earlier today in Toronto, Ontario.

Company’s innovative new product will aid in the early screening and detection of cancer

Kaiser Permanente Ventures (KPV) today announced it has closed its fifth investment fund at $141 million, bringing the total assets under management to more than $500 million.

Epic Sciences, Inc. today announced the presentation of new data demonstrating the feasibility of using its proprietary technology for the detection and characterization of rare cells to guide the treatment of breast cance

Program Pairs GYN Patients with Trained Advocates Who Assist with Clinical, Emotional and Financial Aspects of Surgical Care

Incyte Corporation announced that it will present at the J. P. Morgan 38th Annual Healthcare Conference on Monday, January 13, 2020 at 8:30 am in San Francisco..